NCT04051619View on ClinicalTrials.gov

Oxytocin, Stress, Craving, Opioid Use Disorder

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

January 6, 2020

Primary Completion Date

December 22, 2023

Study Completion Date

December 23, 2023

Conditions

Opioid Use Disorder

Interventions

DRUG

intranasal oxytocin, 40 IU, twice a day for 7 days

Adjunct therapy

Trial Locations (1)

02291

Brown University, Providence

Sponsors

Lead Sponsor

Brown University

All Listed Sponsors

collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

Brown University

OTHER